Systematic review of long-term chemotherapy-induced peripheral neuropathy (CIPN) following adjuvant oxaliplatin for colorectal cancer.
Christina TengJordan CohenSam EggerPrunella L BlinmanJanette L VardyPublished in: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer (2021)
Our summary of reported rates of persistent CIPN indicates substantial long-term toxicity affecting CRC survivors, and will help clinicians estimate CIPN risk and its change over time. The heterogeneity of CIPN measures identified in the review highlights the need for a standardised CIPN assessment.